P035 NUDT15 variance increases DNA-incorporated thiopurine metabolites and lymphocyte apoptosis in patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
ECCO'20 Vienna
2020
P037 Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis
ECCO'20 Vienna
2020
P038 A single-cell transcriptomics approach reveals high-resolution cellular signatures in Crohn’s disease
ECCO'20 Vienna
2020
P039 Regional distribution of TCR Vδ1 and TCR Vδ2 cells in healthy and inflamed mucosa of inflammatory bowel disease
ECCO'20 Vienna
2020
P040 Proteomic characterisation of serum extracellular vesicles in patients with inflammatory bowel diseases: a novel approach for biomarker discovery
ECCO'20 Vienna
2020
P041 Melatonin controls microbiota in colitis through Toll-like receptor 4 signalling
ECCO'20 Vienna
2020
P043 Small intestinal inflammation but not colitis drives pro-inflammatory nutritional antigen-specific T-cell response
ECCO'20 Vienna
2020
P045 Profiling of human circulating dendritic cells and monocytes subsets discriminates type and mucosal status in patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P046 Vitamin D decreases PDIA3 and prevents the enhanced migration of fibroblasts from stricturing Crohn’s disease
ECCO'20 Vienna
2020
P047 Differences in extra cellular matrix remodelling in highly active Crohn’s disease and ulcerative colitis
ECCO'20 Vienna
2020
P048 Mucosal macrophages express elevated levels of HDAC9 in inflamed and uninflamed mucosa of Crohn’s disease, but not ulcerative colitis
ECCO'20 Vienna
2020
P050 Analysis of 61 exclusive enteral nutrition formulas used for induction of remission in Crohn’s disease: new insights on dietary disease triggers
ECCO'20 Vienna
2020
P052 Nuclear magnetic resonance metabolomic profiling of IBD patients under anti-TNF treatment. Are the pathways network deregulated?
ECCO'20 Vienna
2020